Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YMed, Inc. was a medical device company that specialized in the development of steerable catheter systems and vascular access technologies. The company's primary innovation was a proprietary steerable technology designed to improve the navigation and placement of interventional devices within the cardiovascular system. This technology aimed to provide physicians with greater control and precision during complex endovascular procedures. In 2004, YMed was acquired by Boston Scientific to integrate its steerable catheter expertise into their broader interventional cardiology and radiology portfolios. The acquisition allowed for the enhancement of various delivery systems used in the treatment of vascular diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YMed.